P. Brooks, S. Strömblad, L. Sanders, T. Schalscha, R. Aimes, W. Stetler-Stevenson, J. Quigley, D. Cheresh (1996)
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.Cell, 85 5
B. Kallakury, S. Karikehalli, A. Haholu, Christine Sheehan, N. Azumi, J. Ross (2001)
Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 10
Lampert (1998)
Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumorsAm J Pathol, 153
A. Strongin, I. Collier, G. Bannikov, B. Marmer, G. Grant, G. Goldberg (1995)
Mechanism Of Cell Surface Activation Of 72-kDa Type IV CollagenaseThe Journal of Biological Chemistry, 270
Y. Itoh, Akiko Takamura, N. Ito, Y. Maru, Hiroshi Sato, N. Suenaga, T. Aoki, M. Seiki (2001)
Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasionThe EMBO Journal, 20
S. Zucker, M. Drews, Cathleen Conner, H. Foda, Y. DeClerck, K. Langley, W. Bahou, A. Docherty, Jian Cao (1998)
Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)*The Journal of Biological Chemistry, 273
(1999)
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
(1999)
Cell Sci 1997;110(Part 19):2473–2482
E. Deryugina, M. Bourdon, Guang-Xiang Luo, Ralph Reisfeld, A. Strongin (1997)
Matrix metalloproteinase-2 activation modulates glioma cell migration.Journal of cell science, 110 ( Pt 19)
A. Strongin, B. Marmer, G. Grant, G. Goldberg (1993)
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.The Journal of biological chemistry, 268 19
W. Stetler-Stevenson (1996)
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.The American journal of pathology, 148 5
Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, H. Nagase (1998)
Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface*The Journal of Biological Chemistry, 273
S. Braunhut, Marsha Moses (1994)
Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP).The Journal of biological chemistry, 269 18
E. Deryugina, B. Ratnikov, E. Monosov, T. Postnova, R. Discipio, Jeffrey Smith, A. Strongin (2001)
MT1-MMP Initiates Activation of pro-MMP-2 and Integrin αvβ3 Promotes Maturation of MMP-2 in Breast Carcinoma CellsExperimental Cell Research, 263
E. Deryugina, B. Ratnikov, E. Monosov, T. Postnova, R. Discipio, J. Smith, A. Strongin (2001)
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.Experimental cell research, 263 2
Zhiping Wang, Ruth Juttermann, P. Soloway (2000)
TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo *The Journal of Biological Chemistry, 275
Seiki (1999)
Membrane-type matrix metalloproteinasesApmis, 107
B. Annabi, Anthony Pilorget, Nathalie Bousquet-Gagnon, D. Gingras, R. Béliveau (2001)
Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.The Biochemical journal, 359 Pt 2
S. Rajasekaran, L. Palmer, Karina Quan, J. Harper, W. Ball, N. Bander, A. Soler, A. Rajasekaran (2001)
Na,K-ATPase β-Subunit Is Required for Epithelial Polarization, Suppression of Invasion, and Cell MotilityMolecular Biology of the Cell, 12
V. Vergani, A. Garofalo, M. Bani, Patrizia Borsotti, M. Parker, T. Drudis, Giovanni Mazzarol, Giuseppe Viale, R. Giavazzi, W. Stetler-Stevenson, G. Taraboletti (2001)
Inhibition of matrix metalloproteinases by over‐expression of tissue inhibitor of metalloproteinase‐2 inhibits the growth of experimental hemangiomasInternational Journal of Cancer, 91
R. Béliveau, L. Delbecchi, É. Beaulieu, Nathalie Mousseau, Z. Kachra, F. Berthelet, R. Moumdjian, R. Maestro (1999)
Expression of Matrix Metalloproteinases and Their Inhibitors in Human Brain TumorsAnnals of the New York Academy of Sciences, 886
A. Schmitz, E. Govek, B. Böttner, L. Aelst (2000)
Rho GTPases: signaling, migration, and invasion.Experimental cell research, 261 1
L. Coussens, B. Fingleton, L. Matrisian (2002)
Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 295
J. Caterina, S. Yamada, N. Caterina, G. Longenecker, K. Holmbäck, Joanne Shi, Audra Yermovsky, J. Engler, H. Birkedal‐Hansen (2000)
Inactivating Mutation of the Mouse Tissue Inhibitor of Metalloproteinases-2(Timp-2) Gene Alters ProMMP-2 Activation*The Journal of Biological Chemistry, 275
J. Barasch, Jun Yang, J. Qiao, P. Tempst, H. Erdjument-Bromage, Winnie Leung, J. Oliver (1999)
Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.The Journal of clinical investigation, 103 9
P. Brooks, S. Strömblad, L. Sanders, T. Schalscha, R. Aimes, W. Stetler-Stevenson, J. Quigley, D. Cheresh (1996)
Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 85
S. Zucker, Jian Cao, Wen‐Tien Chen (2000)
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatmentOncogene, 19
W. Stetler-Stevenson, S. Aznavoorian, L. Liotta (1993)
Tumor cell interactions with the extracellular matrix during invasion and metastasis.Annual review of cell biology, 9
Mitsutoshi Nakada, Daisuke Kita, Kazuya Futami, J. Yamashita, N. Fujimoto, Hiroshi Sato, Yasunori Okada (2001)
Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.Journal of neurosurgery, 94 3
Mitsuya Murashige, Masaki Miyahara, Norio Shiraishi, Takao Saito, Kimitoshi Kohno, Michio Kobayashi (1996)
Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.Japanese journal of clinical oncology, 26 5
M. Corcoran, W. Stetler-Stevenson (1995)
Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism (*)The Journal of Biological Chemistry, 270
Y. DeClerck (2000)
Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer.European journal of cancer, 36 10
H. Nagase (1997)
Activation mechanisms of matrix metalloproteinases.Biological chemistry, 378 3-4
Z. Kachra, É. Beaulieu, L. Delbecchi, Nathalie Mousseau, F. Berthelet, R. Moumdjian, R. Maestro, R. Béliveau (2004)
Expression of matrix metalloproteinases and their inhibitors in human brain tumorsClinical & Experimental Metastasis, 17
W. Stetler-Stevenson, P. Brown, M. Onisto, A. Levy, L. Liotta (1990)
Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.The Journal of biological chemistry, 265 23
A. Ree, V. Flørenes, V. Flørenes, J. Berg, G. Mælandsmo, J. Nesland, Ø. Fodstad (1997)
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 9
W. Paulus, W. Roggendorf, Detlef Schuppan (2004)
Immunohistochemical investigation of collagen subtypes in human glioblastomasVirchows Archiv A, 413
P. Valente, G. Fassina, A. Melchiori, L. Masiello, M. Cilli, A. Vacca, M. Onisto, L. Santi, W. Stetler-Stevenson, A. Albini (1998)
TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosisInternational Journal of Cancer, 75
D. Grignon, W. Sakr, M. Tóth, V. Ravery, J. Angulo, F. Shamsa, J. Pontes, John Crissman, R. Fridman (1996)
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.Cancer research, 56 7
A. Rigg, N. Lemoine (2001)
Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivoCancer Gene Therapy, 8
Laboratory Investigation – Unpaywall
Published: Jan 1, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.